Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...
You must be a Standard 1 Year member to access this content.
Davis Polk is advising Braze on the deal. Braze (Nasdaq: BRZE) has announced that it has entered into a definitive agreement to acquire North Star, its exclusive...
You must be a Standard 1 Year member to access this content.
Davis Polk provided strategic, regulatory, corporate law, privacy and other advice to Silicon Valley Bridge Bank. First Citizens BancShares, Inc. (Nasdaq: FCNCA) announced on March 27, 2023...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
You must be a Standard 1 Year member to access this content.
Davis Polk advised Natus Medical Incorporated on the deal, while Latham & Watkins represented ArchiMed in the transaction. ArchiMed Group executed its approximately $1.2 billion acquisition of Natus...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell, Ropes & Gray and Skadden, Arps, Slate, Meagher & Flom advised HP on the deal. Wilson Sonsini Goodrich & Rosati represented Poly....
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented McAfee, Fried, Frank, Harris, Shriver & Jacobson and Kirkland & Ellis advised Investor Group in the transaction. Weil, Gotshal & Manges advised...
You must be a Standard 1 Year member to access this content.
Ropes & Gray LLP and Paul Hastings LLP advised on the deal. McAfee Corp. (Nasdaq: MCFE), the device-to-cloud cybersecurity company, entered into a definitive agreement to...
You must be a Standard 1 Year member to access this content.
